Amarin Corp Plc (AMRN)

[HDGabor]

Kiwi,

They are not bankers, they are venture capital investment fund. (BioPharma Funds have raised US $447 million to invest in debt securities and priority royalty tranches collateralized by royalty payments on life sciences products).

ie.:

- August 7, 2012 - Corcept Therapeutics Incorporated (CORT), $30 million
- Dec. 12, 2012 - Curis, Inc. (CRIS), $30 million
- VVUS: 'On March 25, 2013, the Company entered into the Purchase and Sale Agreement between the Company and BioPharma Secured Investments III Holdings Cayman LP, a Cayman Islands exempted limited partnership, providing for the purchase of a debt-like instrument, or the Senior Secured Notes. Under the agreement, the Company received $50 million, less $500,000 in funding and facility payments, at the initial closing on April 9, 2013. The Company had the option but elected not to exercise it to receive an additional $60 million, less $600,000 in a funding payment, at a secondary closing no later than January 15, 2014. For the three months ended March 31, 2014, the imputed interest expense for the Senior Secured Notes was $1.9 million, including $119,000 amortization of deferred financing costs.

interest rate is 10+% (as in case of Amarin)

and again to pay or to defer: it's Amarin choice not depends on Pharmakon's approval

sts66: I could agree with 'we won't know the full Kowa affect for probably another 6-9 months.' only. But get some clue in July / August.